{"id":"W3087736087","doi":"10.1016/j.cgh.2020.09.028","title":"Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis","year":2020,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Placebo; Internal medicine; Clinical trial; Gastroenterology; Clinical endpoint; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003071506,0.0009818812,0.001995289,0.00036343,0.0004162613,0.0008807515,0.0006312128,0.001117505,0.003077631],"category_scores_gemma":[0.001881466,0.0005383424,0.001271156,0.0003518166,0.0007055128,0.00090065,0.0003828094,0.002923804,0.0005235917],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005023702,"about_ca_system_score_gemma":0.0008778166,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003128997,"about_ca_topic_score_gemma":0.0008731796,"domain_scores_codex":[0.9989467,0.0007005951,0.00005635512,0.0001269678,0.00006959553,0.00009985388],"domain_scores_gemma":[0.9984065,0.0003609223,0.0004165799,0.0001379602,0.00009740438,0.0005806939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9224176,0.01786361,0.003373835,0.0004562595,0.0007786606,0.00009432569,0.0001405745,0.0004349096,0.007160518,0.00005644876,0.0008556433,0.04636754],"study_design_scores_gemma":[0.7081735,0.2774609,0.01152519,0.00003429961,0.0003943105,0.0001042774,0.00002366051,0.0004307609,0.0007077179,0.00006569889,0.001063537,0.00001617752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940075,0.002958248,0.0002055044,0.0003876884,0.0001061757,0.0009659954,0.0003048303,0.00004576244,0.001018366],"genre_scores_gemma":[0.9937847,0.001254734,0.0007932436,0.0005035998,0.0002523283,0.001828064,0.0006974132,0.00001209487,0.0008738579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003077631,"threshold_uncertainty_score":0.01624388,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01593300142070462,"score_gpt":0.2946043362788306,"score_spread":0.278671334858126,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}